Palvella Therapeutics (PVLA) Short-term Investments (2017 - 2026)

Palvella Therapeutics (PVLA) has 7 years of Short-term Investments data on file, last reported at $55.5 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $55.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $55.5 million (changed N/A YoY), and the FY2023 annual result was $9.0 million, down 56.32% from the prior year.
• Short-term Investments improved to $55.5 million in Q1 2026 per PVLA's latest filing, from $9.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $55.5 million in Q1 2026 and troughed at $8.6 million in Q1 2023.
• A 3-year average of $20.0 million and a median of $16.5 million in 2022 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 44.32% in 2023 and fell as far as 62.75% in 2023.
• A 3-year view of Short-term Investments shows it stood at $20.5 million in 2022, then tumbled by 56.32% to $9.0 million in 2023, then surged by 518.27% to $55.5 million in 2026.
• Business Quant data shows PVLA's Short-term Investments at $55.5 million in Q1 2026, $9.0 million in Q4 2023, and $11.9 million in Q3 2023.